FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMENT OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: March 9, 2014

Results 1 through 19 of 19

IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES - SIC # 2835

Ticker Exchange Company Financial Reports SIC #
AKER Nasdaq Akers Biosciences, Inc. 2835
CEMI Nasdaq Chembio Diagnostics Inc 2835
CONX Over the counter Corgenix Medical Corporation 2835
DGEN Over the counter Deltagen, Inc. 2835
ERB American ERBA Diagnostics Inc 2835
ETAH Over the counter Eternity Healthcare Inc 2835
GWPC Over the counter Wholehealth Products Inc 2835
IGAP Over the counter Integrity Applications Inc 2835
INOL Over the counter InoLife Technologies Inc 2835
LPDX Nasdaq LipoScience Inc 2835
NANM Over the counter NMI Health Inc 2835
OSUR Nasdaq OraSure Technologies, Inc. 2835
QDEL Nasdaq Quidel Corporation 2835
QTXB Over the counter Quantrx Biomedical Corporation 2835
RGDX Nasdaq Response Genetics, Inc. 2835
RSRT Over the counter Realsource Residential Inc 2835
SDOI Over the counter Special Diversified Opportunit 2835
TRIB Nasdaq Trinity Biotech plc (ADR) 2835
VRML Nasdaq Vermillion, Inc. 2835
Results 0 through 19 of 19